Huw Jones

Huw Jones is a seasoned executive in the biopharmaceutical sector, currently serving as Chief Executive Officer at Evgen Pharma and Non-Executive Director at OBN (UK) Ltd and Ixaka. With extensive experience as the owner of Daffodil Consulting LLP since 2002, Huw has provided strategic advice to over 35 companies. Previously, Huw was Chairman of Chronos Therapeutics and served as Strategic Advisor at GEN2 NEUROSCIENCE LTD. Huw’s notable past roles include President at CV Therapeutics and SVP/MD at Elan Pharmaceuticals, as well as positions at SmithKline Beecham and Ardana PLC. Huw holds a Ph.D. in Pharmacology from the University of Birmingham and a BSc in Pharmacology from the University of Wales, Cardiff.